The liability to smoking initiation, nicotine dependence, and intervention encouraged us to study the unexplored genomic and epigenomic regulatory factors of kynurenine 3-monooxygenase gene, KMO. The gene linked to several neuropsychiatric diseases by modulating KA cellular levels (Erhardt et al., 2017). Here, KMO is linked to nicotine dependence.